Dr. Hudson is a tenured Professor in the Department of Clinical Pharmacy and Translational Science and the Department of Medicine (Division of Nephrology) at the University of Tennessee (UT) Health Science Center and a Clinical Pharmacist specializing in nephrology at Methodist Hospital in Memphis, TN. Prior to joining the faculty at UT, she completed a 2-year Nephrology fellowship at Virginia Commonwealth University-Medical College of Virginia. Her clinical practice is focused on the management of patients with both acute and chronic kidney disease through her activities at Methodist and the outpatient dialysis centers. Dr. Hudson currently serves as residency program director for the ASHP-accredited PGY2 internal medicine residency. Her teaching and research interests focus on drug disposition in individuals with chronic kidney disease and during renal replacement therapy. She has been recognized as a Fellow of the American Society of Nephrology, the American College of Clinical Pharmacy and the National Kidney Foundation.
Presenting modules:
A majority of medications are primarily eliminated by the kidneys. As kidney function declines in chronic kidney disease, altered pharmacokinetics necessitate dosage adjustment to minimize toxicity risk while ensuring optimal efficacy. This module will provide the underpinning pharmacokinetic rationale for these medication dosage adjustments, using practical examples of commonly used medications in clinical practice.